TY - JOUR
T1 - Workers with Lived and Living Experience
T2 - Characteristics and Wellbeing in the Australian AOD Sector
AU - Kostadinov, Victoria
AU - Skinner, Natalie
AU - Duraisingam, Vinita
PY - 2023/12
Y1 - 2023/12
N2 - Introduction: Little data exists examining workers with lived/living experience of alcohol and other drug (AOD) use who are not in designated peer roles. The prevalence of these workers within the national workforce, and their levels of wellbeing, are currently unknown. The current study therefore explored the prevalence, characteristics, and predictors of wellbeing among workers with different types of lived experience (personal vs family/other) compared to those without any reported lived experience.Methods: A cross-sectional survey was conducted of the Australian AOD workforce. Group differences were explored on variables of interest via frequency statistics, χ2 tests of independence, multivariate analysis of variance, and linear regression.Results: Of the 986 AOD workers in direct client service roles, 2.4% were in a designated peer role, but 67.2% reported lived experience (34.5% personal lived experience and 32.8% family/other lived experience). Substantial proportions had not disclosed their lived experience to their workplace (27.4% with personal lived experience and 43.3% with other lived experience). Wellbeing (i.e., levels of burnout and engagement) did not differ significantly between groups. Predictors of wellbeing across all three groups included age, work intensity (e.g., heavy workloads), and finding work to be personally meaningful; additional differences between groups were also identified.Discussion: More than two-thirds of AOD workers in Australia have some form of lived experience, however this is not reflected in the number of peer roles. Initiatives that reach all workers with lived experience are required to safeguard their wellbeing, enhance recruitment and retention, and support best practice.
AB - Introduction: Little data exists examining workers with lived/living experience of alcohol and other drug (AOD) use who are not in designated peer roles. The prevalence of these workers within the national workforce, and their levels of wellbeing, are currently unknown. The current study therefore explored the prevalence, characteristics, and predictors of wellbeing among workers with different types of lived experience (personal vs family/other) compared to those without any reported lived experience.Methods: A cross-sectional survey was conducted of the Australian AOD workforce. Group differences were explored on variables of interest via frequency statistics, χ2 tests of independence, multivariate analysis of variance, and linear regression.Results: Of the 986 AOD workers in direct client service roles, 2.4% were in a designated peer role, but 67.2% reported lived experience (34.5% personal lived experience and 32.8% family/other lived experience). Substantial proportions had not disclosed their lived experience to their workplace (27.4% with personal lived experience and 43.3% with other lived experience). Wellbeing (i.e., levels of burnout and engagement) did not differ significantly between groups. Predictors of wellbeing across all three groups included age, work intensity (e.g., heavy workloads), and finding work to be personally meaningful; additional differences between groups were also identified.Discussion: More than two-thirds of AOD workers in Australia have some form of lived experience, however this is not reflected in the number of peer roles. Initiatives that reach all workers with lived experience are required to safeguard their wellbeing, enhance recruitment and retention, and support best practice.
KW - alcohol and other drugs
KW - lived experience practitioners
KW - worker wellbeing
KW - workforce development
UR - http://www.scopus.com/inward/record.url?scp=85175965313&partnerID=8YFLogxK
U2 - 10.1177/00914509231210928
DO - 10.1177/00914509231210928
M3 - Article
AN - SCOPUS:85175965313
SN - 0091-4509
VL - 50
SP - 527
EP - 540
JO - Contemporary Drug Problems
JF - Contemporary Drug Problems
IS - 4
ER -